Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evolent Health (EVH)
NYSE:EVH
EVH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.45 - $35.00
Previous CloseN/A
Volume268.11K
Average Volume (3M)2.09M
Market Cap
$1.17B
Enterprise Value$3.96B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.16
Next Earnings
Feb 20, 2025EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding116,563,910
10 Day Avg. Volume1,695,778
30 Day Avg. Volume2,089,844
Standard Deviation0.19
R-Squared0.16
Alpha0.00124
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.47
Price to Cash Flow (P/CF)15.60
P/FCF Ratio23.60
Enterprise Value/Market Cap3.39
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.60
Enterprise Value/Ebitda60.93
Forecast
1Y Price Target
$15.54Price Target Upside55.09% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
---
Evolent Health News
PremiumCompany Announcements
Evolent Health Strengthens Board with Strategic Changes
---
Bulls Say, Bears Say
Bulls Say
Client RetentionEvolent was able to maintain 100% client retention through the Performance Suite contract negotiations.
Contract SecurityTwo-thirds of PS revenue is now covered under adjusted contracts that significantly narrow downside risk in elevated cost & utilization environments.
Growth PotentialEVH represents an attractive buying opportunity, particularly given its ability to drive 20%+ growth, beginning in 2026.
Bears Say
Membership DeclinesThere is possibility for significant membership declines from Medicare Advantage making plan changes to bolster profitability or terminating plans altogether in certain markets.
Profitability ConcernsElevated health utilization and heightened cancer costs have persisted, leading to lower profitability expectations.
Revenue ChallengesThe upcoming year, 2025, may have some negative revenue and adjusted EBITDA growth optics.
---
Ownership Overview
1.29% Insiders
38.29% Mutual Funds
2.04% Other Institutional Investors
43.11% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EVH FAQ
What was Evolent Health’s price range in the past 12 months?
Evolent Health lowest stock price was $9.45 and its highest was $35.00 in the past 12 months.
What is Evolent Health’s market cap?
Evolent Health’s market cap is $1.17B.
When is Evolent Health’s upcoming earnings report date?
Evolent Health’s upcoming earnings report date is Feb 20, 2025 which is in 3 days.
How were Evolent Health’s earnings last quarter?
Evolent Health released its earnings results on Nov 07, 2024. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.31 by -$0.27.
Is Evolent Health overvalued?
According to Wall Street analysts Evolent Health’s price is currently Undervalued.
Does Evolent Health pay dividends?
Evolent Health does not currently pay dividends.
What is Evolent Health’s EPS estimate?
Evolent Health’s EPS estimate is 0.03.
How many shares outstanding does Evolent Health have?
Evolent Health has 116,563,910 shares outstanding.
What happened to Evolent Health’s price movement after its last earnings report?
Evolent Health reported an EPS of $0.04 in its last earnings report, missing expectations of $0.31. Following the earnings report the stock price went down -45.625%.
Which hedge fund is a major shareholder of Evolent Health?
Currently, no hedge funds are holding shares in EVH
---
Evolent Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.54 (55.09% Upside)
$15.54 (55.09% Upside)
Blogger Sentiment
Bullish
EVH Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 63.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.8%
Last 30 Days ▼ 7.0%
Last 30 Days ▼ 7.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.50%
12-Months-Change
Fundamentals
Return on Equity
-6.77%
Trailing 12-Months
Asset Growth
-6.29%
Trailing 12-Months
Company Description
Evolent Health
Evolent Health, Inc. engages in the provision of health care delivery and payment services. Its solutions include population health management, health plan administration and third party administration, network performance management, risk adjustment, pharmacy benefit management, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services segment and True Health segment. The Services segment includes three types of services designed to help partners manage patient health; value-based care services, specialty care management services and comprehensive health plan administration services. The True Health segment, which operates a health plan in New Mexico, and provides reinsurance to NMHC, takes on certain insurance and underwriting costs in pricing its premiums. The company was founded by Frank J. Williams, Seth B. Blackley, and Tom Peterson in August 2011 and is headquartered in Arlington, VA.
---
EVH Company Deck
---
EVH Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted Evolent's strong market position and record business signings, but was overshadowed by significant challenges related to increased medical costs, earnings shortfall, and the need for additional rate negotiations. Despite long-term growth expectations, the immediate financial performance and operational hurdles present a cautious outlook.Read More>---
EVH Stock 12 Month Forecast
Average Price Target
$15.54
▲(55.09% Upside)
Technical Analysis
Best Analysts Covering EVH
1 Year
1 Year Success Rate
20/47 ratings generated profit
1 Year Average Return
+10.90%
reiterated a buy rating 26 days ago
Copying Richard Close's trades and holding each position for 1 Year would result in 42.55% of your transactions generating a profit, with an average return of +10.90% per trade.
---